25 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24654918	19	Pharmacophoric modifications lead to superpotentavß3 integrin ligands with suppresseda5ß1 activity.	Technische Universit£T M£Nchen
23362923	59	Biselectivity of isoDGR peptides for fibronectin binding integrin subtypesa5ß1 andavß6: conformational control through flanking amino acids.	Technische Universit£T M£Nchen
17399986	114	R-isomers of Arg-Gly-Asp (RGD) mimics as potent alphavbeta3 inhibitors.	Pfizer
17387018	74	Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization.	Pfizer
16621534	87	Synthesis of pyrazoles and isoxazoles as potent alpha(v)beta3 receptor antagonists.	Pfizer
16303301	44	Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic properties.	Pfizer
16298127	80	Convergent, parallel synthesis of a series of beta-substituted 1,2,4-oxadiazole butanoic acids as potent and selective alpha(v)beta3 receptor antagonists.	Pfizer
11855984	102	Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins.	Merck
32094009	36	Novel cilengitide-based cyclic RGD peptides as ?v?	Division of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
30657681	262	Selective Targeting of Integrin ?v?8 by a Highly Active Cyclic Peptide.	Technische Universit£T M£Nchen
31381331	70	Profile of a Highly Selective Quaternized Pyrrolidine Betaine ?	Glaxosmithkline Medicines Research Centre
31497959	48	Discovery of an Orally Bioavailable Pan ?v Integrin Inhibitor for Idiopathic Pulmonary Fibrosis.	Glaxosmithkline Medicines Research Centre
24568695	76	Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.	University of Bradford
25408832	152	Structure Activity Relationships of ?v Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.	University of Nottingham
30215258	228	Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic ?	University of Strathclyde